Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?

Affiliations

Comment

Matthias Guckenberger. Int J Radiat Oncol Biol Phys. 2015.

. 2015 Nov 15;93(4):765-8.

doi: 10.1016/j.ijrobp.2015.08.025. Epub 2015 Oct 19.

¹ Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: Matthias.Guckenberger@usz.ch.

No abstract available

Comment on

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).
Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Timmerman RD, Choy H. Videtic GM, et al. Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):757-64. doi: 10.1016/j.ijrobp.2015.07.2260. Epub 2015 Jul 17. Int J Radiat Oncol Biol Phys. 2015. PMID: 26530743 Free PMC article. Clinical Trial.